Eledon Pharmaceuticals, Inc.
DE ˙ DB ˙ US28617K1016
2,92 € ↓ -0,04 (-1,35%)
2026-06-04
AKTIENPREIS
SecurityDE:2TK / Eledon Pharmaceuticals, Inc.
InstitutionGeode Capital Management, Llc
Latest Disclosed Ownership1,791,783 shares
Latest Disclosed Value $ 5,520,050
Geode Capital Management, Llc reports 26.04% increase in ownership of 2TK / Eledon Pharmaceuticals, Inc.

On May 15, 2026 - Geode Capital Management, Llc filed a 13F-HR form disclosing ownership of 1,791,783 shares of Eledon Pharmaceuticals, Inc. (DE:2TK) valued at $4,121,101 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 9, 2026 disclosing 1,421,617 shares of Eledon Pharmaceuticals, Inc.. This represents a change in shares of 26.04% during the quarter. The current value of the position is $5,232,006 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F ELEDON PHARMACEUTICALS COM 28617K101 1,791,783 370,166 26.04 5,520 157.22 0.0002
2026-02-09 2025-12-31 13F ELEDON PHARMACEUTICALS COM 28617K101 1,421,617 52,677 3.85 2,147 -39.48 0.0001
2025-11-12 2025-09-30 13F ELEDON PHARMACEUTICALS COM 28617K101 1,368,940 -15,000 -1.08 3,546 -5.47 0.0002
2025-08-08 2025-06-30 13F ELEDON PHARMACEUTICALS COM 28617K101 1,383,940 717,223 107.58 3,751 65.90 0.0003
2025-05-13 2025-03-31 13F ELEDON PHARMACEUTICALS COM 28617K101 666,717 3,616 0.55 2,261 -17.27 0.0002
2025-02-12 2024-12-31 13F ELEDON PHARMACEUTICALS COM 28617K101 663,101 285,043 75.40 2,733 190.44 0.0002
2024-11-12 2024-09-30 13F ELEDON PHARMACEUTICALS COM 28617K101 378,058 33,569 9.74 942 3.52 0.0001
2024-08-09 2024-06-30 13F ELEDON PHARMACEUTICALS COM 28617K101 344,489 163,588 90.43 910 144.35 0.0001
2024-05-13 2024-03-31 13F ELEDON PHARMACEUTICALS COM 28617K101 180,901 4,862 2.76 373 17.72 0.0000
2024-02-13 2023-12-31 13F ELEDON PHARMACEUTICALS COM 28617K101 176,039 0 0.00 317 31.12 0.0000
2023-11-13 2023-09-30 13F ELEDON PHARMACEUTICALS COM 28617K101 176,039 6,389 3.77 241 3.88 0.0000
2023-08-11 2023-06-30 13F ELEDON PHARMACEUTICALS COM 28617K101 169,650 40,499 31.36 232 -23.68 0.0000
2023-05-15 2023-03-31 13F ELEDON PHARMACEUTICALS COM 28617K101 129,151 0 0.00 305 0.0000
2023-02-13 2022-12-31 13F ELEDON PHARMACEUTICALS COM 28617K101 129,151 -314 -0.24 0 -100.00 0.0000
2022-11-14 2022-09-30 13F ELEDON PHARMACEUTICALS COM 28617K101 129,465 679 0.53 357 13.69 0.0001
2022-08-12 2022-06-30 13F ELEDON PHARMACEUTICALS COM 28617K101 128,786 2,076 1.64 314 -37.07 0.0000
2022-05-13 2022-03-31 13F ELEDON PHARMACEUTICALS COM 28617K101 126,710 0 0.00 499 -10.57 0.0001
2022-02-11 2021-12-31 13F ELEDON PHARMACEUTICALS COM 28617K101 126,710 -848 -0.66 558 -29.19 0.0001
2021-11-12 2021-09-30 13F ELEDON PHARMACEUTICALS COM 28617K101 127,558 2,944 2.36 788 -20.00 0.0001
2021-08-13 2021-06-30 13F ELEDON PHARMACEUTICALS COM 28617K101 124,614 25,491 25.72 985 -7.08 0.0001
2021-05-12 2021-03-31 13F ELEDON PHARMACEUTICALS COM 28617K101 99,123 99,123 1,060 0.0002
2021-02-12 2020-12-31 13F NOVUS THERAPEUTICS COMSTK 67011N105 0 -12,775 -100.00 0 -100.00
2020-11-13 2020-09-30 13F NOVUS THERAPEUTICS COMSTK 67011N105 12,775 0 0.00 12 140.00 0.0000
2020-08-13 2020-06-30 13F NOVUS THERAPEUTICS COM 67011N105 12,775 0 0.00 5 25.00 0.0000
2020-05-14 2020-03-31 13F NOVUS THERAPEUTICS COM 67011N105 12,775 0 0.00 4 -42.86 0.0000
2020-02-20 2019-12-31 13F/A-1 NOVUS THERAPEUTICS COM 67011N105 12,775 0 0.00 7 -12.50 0.0000
2020-02-13 2019-12-31 13F NOVUS THERAPEUTICS COM 67011N105 12,775 0 7 0.8921
2019-11-12 2019-09-30 13F NOVUS THERAPEUTICS COM 67011N105 12,775 0 0.00 8 -33.33 0.0000
2019-08-14 2019-06-30 13F NOVUS THERAPEUTICS COM 67011N105 12,775 1,063 9.08 12 -74.47 0.0000
2019-05-14 2019-03-31 13F NOVUS THERAPEUTICS COM 67011N105 11,712 0 0.00 47 161.11 0.0000
2019-03-06 2018-12-31 13F/A-1 NOVUS THERAPEUTICS COM 67011N105 11,712 0 0.00 18 -66.67 0.0000
2019-02-13 2018-12-31 13F NOVUS THERAPEUTICS COM 67011N105 11,712 0 18
2018-11-13 2018-09-30 13F NOVUS THERAPEUTICS COM 67011N105 11,712 11,712 54 0.0000
2017-08-14 2017-06-30 13F TOKAI PHARMACEUTICALS COM 88907J107 0 -84,831 -100.00 0 -100.00
2017-06-21 2017-03-31 13F/A-1 TOKAI PHARMACEUTICALS COM 88907J107 84,831 -1,497 -1.73 70 -16.67 0.0000
2017-05-12 2017-03-31 13F TOKAI PHARMACEUTICALS COM 88907J107 84,831 70
2017-02-14 2016-12-31 13F TOKAI PHARMACEUTICALS COM 88907J107 86,328 12,157 16.39 84 -25.66 0.0000
2016-11-10 2016-09-30 13F TOKAI PHARMACEUTICALS COM 88907J107 74,171 16,194 27.93 113 -64.58 0.0001
2016-08-12 2016-06-30 13F TOKAI PHARMACEUTICALS COM 88907J107 57,977 5,423 10.32 319 8.50 0.0002
2016-05-13 2016-03-31 13F TOKAI PHARMACEUTICALS COM 88907J107 52,554 -65 -0.12 294 -35.81 0.0002
2016-02-12 2015-12-31 13F TOKAI PHARMACEUTICALS COM 88907J107 52,619 1,428 2.79 458 -13.42 0.0003
2015-11-13 2015-09-30 13F TOKAI PHARMACEUTICALS COM 88907J107 51,191 8,196 19.06 529 -7.36 0.0003
2015-08-14 2015-06-30 13F TOKAI PHARMACEUTICALS COM 88907J107 42,995 2,907 7.25 571 26.33 0.0003
2015-05-14 2015-03-31 13F TOKAI PHARMACEUTICALS COM 88907J107 40,088 2,503 6.66 452 -18.41 0.0003
2015-02-12 2014-12-31 13F TOKAI PHARMACEUTICALS COM 88907J107 37,585 37,585 554 0.0003
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.